Co-funded by the Erasmus+ Programme of the European Union
It is a known fact that antibiotic resistance (ABR) is a multisectoral problem and to tackle it the approach also should be in multi directions which can be called a ‘one health’ approach. A systematic analysis has estimated that in 2019 globally around 4.95 million people lost their lives because…
The spread of antibiotic resistance has increased interest in combination-based treatments. Despite extensive research into the effects of drug combinations on bacterial growth, Much less is known about their effects on bacterial long-term clearance, particularly at cidal, clinically relevant concentrations. The authors systematically quantify Staphylococcus aureus survival during prolonged exposure…
Antimicrobial resistance (AMR) is a One Health problem underpinned by complex drivers and behaviours. This is particularly so in low – and middle-income countries (LMICs), where social and systemic factors fuel (mis)use and drive AMR. Behavioural change around antimicrobial use could safeguard both existing and future treatments. However, changing behaviour…
Antimicrobial resistance is a global public health challenge. In 2015, World Health Organization urged all its member states to develop respective national action plans to curb this crisis. In response to this, the Ministry of Health and Sports, Myanmar, published the National Action Plan for Containment of AMR in Myanmar…
Antibiotics have been crucial in the success of modern medicine in the fight against infectious diseases. Over recent decades, antibiotic resistance has emerged as a significant challenge by reducing the effectiveness of antibiotics in this fight. Antibiotics are widely used after childbirth to prevent potential infections and complications such as…
Antibiotic resistance is a public health threat of the utmost importance, especially when it comes to children: according to WHO data, infections caused by multidrug resistant bacteria produce 700,000 deaths across all ages, of which around 200,000 are newborns. This surging issue has multipronged roots that are specific to the…
Prior to the SARS-CoV-2 pandemic, antibiotic resistance was identified as a major global health care concern. Although fungal infections remain largely unknown to the general public, total attributable annual deaths are comparable to or exceed global mortalities from malaria, tuberculosis, or HIV. The impact of fungal infections has been exacerbated…
The increasing issue of antibiotic resistance is a great challenge to the pharmaceutical industry. The pressure of developing newer, better compounds with capacity to kill or inhibit the growth of antibiotic resistant organisms is huge. In this direction, nanoparticles are gaining a lot of attention. For instance, the use of…
Escherichia coli (E. coli) is a bacterium that inhabits and colonize the guts of human beings and animals. Particular strains of this bacterium called ‘Shiga toxin-producing strains of E. coli’ (STECs) cause infections in humans due to the intake of food which is not cooked, partially cooked or contaminated with…
The use of antibiotics on a regular and excessive basis is a major factor in the spread of antibiotic-resistant bacteria. Patients discharge un-metabolized or relatively low doses of non-metabolized antibiotics through urine and stool, which might enter into the environment through sewage disposal and promote the emergence of antibiotic resistant…
Project reference: 598515-EPP-1-2018-1-IN-EPPKA2-CBHE-JP